Fasting Blood Glucose Ranges
For Diagnosis
For diagnosing diabetes, a fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) after at least 8 hours without caloric intake is diagnostic, while prediabetes is defined as fasting glucose between 100-125 mg/dL. 1, 2
Diabetes Diagnostic Thresholds
- Fasting plasma glucose ≥126 mg/dL (7.0 mmol/L) confirms diabetes when measured after at least 8 hours of fasting 1
- Confirmation with repeat testing is required unless the patient has unequivocal hyperglycemia or classic symptoms 1, 2
- Alternative diagnostic criteria include HbA1c ≥6.5% (using NGSP-certified laboratory methods), 2-hour glucose ≥200 mg/dL during oral glucose tolerance test, or random glucose ≥200 mg/dL with symptoms 1
Prediabetes Diagnostic Thresholds
- Fasting plasma glucose 100-125 mg/dL defines impaired fasting glucose (IFG) per American Diabetes Association criteria 2, 3
- The World Health Organization uses a higher threshold of 110-125 mg/dL for IFG 2
- HbA1c of 5.7-6.4% also indicates prediabetes 1, 2, 3
- 2-hour glucose of 140-199 mg/dL during oral glucose tolerance test defines impaired glucose tolerance 2, 3
Critical caveat: The difference between 99 and 100 mg/dL is clinically arbitrary—fasting glucose has 12-15% day-to-day variability, meaning the same person could measure differently on consecutive days without actual metabolic change. 2 Always confirm abnormal results with repeat testing. 2
For Maintenance in Known Diabetes
For most non-pregnant adults with established diabetes, target fasting/preprandial glucose of 80-130 mg/dL (4.4-7.2 mmol/L), which correlates with achieving HbA1c <7.0% and reduces microvascular complications. 4
Standard Targets by Patient Category
Healthy adults with diabetes:
Older adults - stratified by health status:
- Healthy older adults (few comorbidities, intact function): 80-130 mg/dL fasting 4
- Complex/intermediate health (multiple comorbidities, mild-moderate cognitive impairment): 90-150 mg/dL fasting 4
- Very complex/poor health (end-stage illness, severe cognitive impairment, ADL dependence): 100-180 mg/dL fasting 4
More stringent targets (when appropriate):
- Fasting glucose 110-140 mg/dL (6.1-7.8 mmol/L) for selected patients with short diabetes duration, long life expectancy, no significant cardiovascular disease, and no severe hypoglycemia history 4
Hospitalized patients:
- Target range: 140-180 mg/dL (7.8-10.0 mmol/L) for both critically ill and non-critically ill patients 4, 5
- Initiate insulin therapy when glucose persistently exceeds 180 mg/dL 4, 5
- Never target <110 mg/dL in critically ill patients—the NICE-SUGAR trial demonstrated that intensive glucose control targeting 81-108 mg/dL increased mortality by 2% compared to 140-180 mg/dL targets 5
Critical Hypoglycemia Thresholds to Avoid
- <70 mg/dL (3.9 mmol/L): Requires immediate treatment with 15-20g fast-acting carbohydrate 4
- <54 mg/dL (3.0 mmol/L): Clinically significant hypoglycemia with neuroglycopenic symptoms requiring urgent intervention 4
Individualization Algorithm
When determining appropriate fasting glucose targets, systematically assess: 4
- Duration of diabetes (shorter duration allows tighter control)
- Life expectancy (longer expectancy favors tighter control)
- History of hypoglycemia (previous episodes require looser targets)
- Comorbidity burden (more comorbidities require looser targets)
- Cognitive and functional status (impairment requires looser targets)
Common Pitfalls
Don't panic at a single fasting glucose of 100 mg/dL—given the 12-15% day-to-day variability in glucose measurements, always confirm with repeat testing before diagnosing prediabetes. 2
Don't rely solely on fasting glucose for prediabetes screening—HbA1c and 2-hour oral glucose tolerance testing identify different at-risk populations with incomplete concordance between tests. 2 In high-risk populations like young African Americans, fasting glucose alone detected only 27.4% of prediabetic cases, while complete oral glucose tolerance testing detected 87.1%. 6
Ensure proper sample handling—plasma should be separated immediately or samples kept on ice to prevent glycolysis, as glucose has poor preanalytical stability. 2